Medical company’s acquisition OK’d

A Japanese company has received Federal Trade Commission clearance to acquire Bolton Medical, a Sunrise manufacturer of stents and other medical devices.

The proposed acquisition of Bolton, which employs about 300 people in Sunrise, was announced by Terumo Corp. of Tokyo in January. The FTC listed the companies as receiving premerger authorization to proceed with the merger.

Bolton Medical in Sunrise couldn’t be reached on Tuesday.

Terumo, a publicly held medical device company whose stock is traded on the Tokyo Stock Exchange, has more than $5 billion in sales and operations in more than 160 countries.

“The acquisition will enhance Terumo’s existing product portfolio in the global stent graft market and our vascular graft business will be further strengthened in the U.S., in what is the largest stent graft market today,” said Shinjiro Sato, president of Cardiac and Vascular Co., which is part of Terumo Corp.

Bolton was acquired through its parent company, WerfenLife Group, a global research and development and manufacturing company based in Barcelona, Spain. WerfenGroup’s endovascular division, which includes Bolton, saw more than 10 percent growth in 2015, according to the company’s annual report.

The transaction is expected to close in a few months. The purchase price was not disclosed.

Bolton Medical, which was founded in Sunrise in 2003, was named the South Florida Manufacturer of the Year in 2012 by the South Florida Manufacturers Association of Pompano Beach.

In 2012, the company received FDA approval of its stent designed to prevent thoracic aorta aneurysms. The implanted stent bypasses the weakened wall of the aorta, the largest artery that carries blood from the heart to the rest of the body.